{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-031201","form_type":"8-K","ticker":null,"cik":"0001792581","company_name":"Kiromic Biopharma, Inc.","filed_at":"2023-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.563731+00:00","generated_at":"2026-06-18T05:42:17.762605+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Kiromic BioPharma effects 1-for-30 reverse stock split to regain Nasdaq compliance","bullets":["Reverse split at 1-for-30 effective March 10, 2023 at 4:01 pm ET; trading on split-adjusted basis March 13.","Post-split shares outstanding approximately 966,758; fractional shares rounded up to whole share.","Trading symbol KRBP unchanged; new CUSIP number 497634204.","Split approved by stockholders on March 7, 2023; board set ratio at 1-for-30.","Primary purpose: meet Nasdaq minimum bid price requirement for continued listing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-031201","json":"https://secwatch.observer/filing/0001104659-23-031201.json","markdown":"https://secwatch.observer/filing/0001104659-23-031201.md","text":"https://secwatch.observer/filing/0001104659-23-031201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1792581/000110465923031201/0001104659-23-031201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1792581/000110465923031201/tm239172d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T05:42:17.762605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f3aef6fb948624488ba9b8b1a64d870a6de47378","claim":"Kiromic Biopharma, Inc.: Amended certificate of incorporation to effect a 1-for-30 reverse stock split, effective 4:01 p.m. ET on March 10, 2023 (effective 2023-03-10).","evidence_excerpt":"On March 10, 2023, the Company filed with the Secretary of State of the State of Delaware a certificate of amendment to its certificate of incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1792581/000110465923031201/0001104659-23-031201-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-03-10"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}